Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoko Takebe

Showing results (71-80 of 140) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Phase II study of dasatinib in patients with advanced non-small-cell lung cancerFaye M Johnson, B Nebiyou Bekele, Lei Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2014
Pilot clinical trial of hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinomaEdward J Kim, Vaibhav Sahai, Ethan V Abel, et al.
Cancer Chemotherapy and Pharmacology|February 19, 2010
A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignanciesPaul K Paik, Charles M Rudin, Andrew Brown, et al.
Current Problems in Cancer|March 28, 2017
Pediatric oncology enters an era of precision medicineNita L Seibel, Katherine Janeway, Carl E Allen, et al.
Cancer Research Communications|February 11, 2025
Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical StudyWilliam C Reinhold, Elisabetta Marangoni, Fathi Elloumi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patientsAshraf Z Badros, Olga Goloubeva, Aaron P Rapoport, et al.
Molecular Cancer Therapeutics|April 22, 2026
TRPM4 Expression as a Predictive Biomarker and a Mechanistic Driver of Acetalax Activity in Prostate Cancer: Preclinical Efficacy StudiesYuka Hoshi-Kadonosawa, William C Reinhold, Daiki Taniyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2013
Evaluation of food effect on pharmacokinetics of vismodegib in advanced solid tumor patientsManish R Sharma, Theodore G Karrison, Bethany Kell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcomeJan Brabender, Henning Usadel, Ralf Metzger, et al.
Journal of Neuro-Oncology|December 29, 2022
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449Andrew E Sloan, Charles J Nock, Xiaobu Ye, et al.
Pageof 14

Showing results (71-80 of 140) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Phase II study of dasatinib in patients with advanced non-small-cell lung cancerFaye M Johnson, B Nebiyou Bekele, Lei Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2014
Pilot clinical trial of hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinomaEdward J Kim, Vaibhav Sahai, Ethan V Abel, et al.
Cancer Chemotherapy and Pharmacology|February 19, 2010
A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignanciesPaul K Paik, Charles M Rudin, Andrew Brown, et al.
Current Problems in Cancer|March 28, 2017
Pediatric oncology enters an era of precision medicineNita L Seibel, Katherine Janeway, Carl E Allen, et al.
Cancer Research Communications|February 11, 2025
Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical StudyWilliam C Reinhold, Elisabetta Marangoni, Fathi Elloumi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patientsAshraf Z Badros, Olga Goloubeva, Aaron P Rapoport, et al.
Molecular Cancer Therapeutics|April 22, 2026
TRPM4 Expression as a Predictive Biomarker and a Mechanistic Driver of Acetalax Activity in Prostate Cancer: Preclinical Efficacy StudiesYuka Hoshi-Kadonosawa, William C Reinhold, Daiki Taniyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2013
Evaluation of food effect on pharmacokinetics of vismodegib in advanced solid tumor patientsManish R Sharma, Theodore G Karrison, Bethany Kell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcomeJan Brabender, Henning Usadel, Ralf Metzger, et al.
Journal of Neuro-Oncology|December 29, 2022
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449Andrew E Sloan, Charles J Nock, Xiaobu Ye, et al.
Pageof 14